FDANonrulemakingFDA-2021-N-0891
Who commented on this docket
Reauthorization of the Prescription Drug User Fee Act; Public Meeting; Request for Comments
14 organizations filed 14 public comments on Reauthorization of the Prescription Drug User Fee Act; Public Meeting; Request for Comments, at the Food and Drug Administration. The comment window closed 1734d ago.
Organizations
14
Comments
14
RIN
—
Comment window
closed 1734d ago
Commenters (14)
- a center of the Milken Institutetrade assoc.1 filing · confidence 85%
- Alliance for Aging Researchtrade assoc.1 filing · confidence 85%
- Alliance for Regenerative Medicine - Washingtontrade assoc.1 filing · confidence 85%
- American Pharmacists Association (APhA)trade assoc.1 filing · confidence 97%
- American Society of Gene & Cell Therapytrade assoc.1 filing · confidence 85%
- EveryLife Foundation for Rare Diseasestrade assoc.1 filing · confidence 85%
- LUNGevity Foundationtrade assoc.1 filing · confidence 85%
- Lupus Foundation of Americatrade assoc.1 filing · confidence 85%
- Muscular Dystrophy Associationtrade assoc.1 filing · confidence 85%
- National Alliance for Caregivingtrade assoc.1 filing · confidence 85%
- Personalized Medicine Coalitiontrade assoc.1 filing · confidence 85%
- Physicians Committee for Responsible Medicinetrade assoc.1 filing · confidence 85%
- The RWE Alliancetrade assoc.1 filing · confidence 85%
- Vizient Inc.unverified attribution1 filing · confidence 70%
Attribution is name-based and imperfect. regulations.gov data is public record.